Instagram as an Educational Platform for Familial Mediterranean Fever: A 33-Month Experience

C. Grandpeix-Guyodo, MD, Sorbonne University, Internal Medicine Department, DMU3ID, FHU INFLAMME, Tenon Hospital, AP-HP, Paris, France; National Reference Center for Auto-Inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), France; ERN RITA (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Disease Network), Utrecht, the Netherlands.

Z. Aknouche, MSc, Sorbonne University, Internal Medicine Department, DMU3ID, FHU INFLAMME, Tenon Hospital, AP-HP, Paris, France; National Reference Center for Auto-Inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), France; ERN RITA (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Disease Network), Utrecht, the Netherlands.

P. Mertz, MD, Sorbonne University, Internal Medicine Department, DMU3ID, FHU INFLAMME, Tenon Hospital, AP-HP, Paris, France; National Reference Center for Auto-Inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), France; ERN RITA (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Disease Network), Utrecht, the Netherlands; Pediatric Department, Versailles Hospital, Le Chesnay, France.

L. Savey, MD, Sorbonne University, Internal Medicine Department, DMU3ID, FHU INFLAMME, Tenon Hospital, AP-HP, Paris, France; National Reference Center for Auto-Inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), France; ERN RITA (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Disease Network), Utrecht, the Netherlands.

M. Delplanque, MD, Sorbonne University, Internal Medicine Department, DMU3ID, FHU INFLAMME, Tenon Hospital, AP-HP, Paris, France; National Reference Center for Auto-Inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), France; ERN RITA (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Disease Network), Utrecht, the Netherlands.

S.H. Aloui, MSc, Sorbonne University, Internal Medicine Department, DMU3ID, FHU INFLAMME, Tenon Hospital, AP-HP, Paris, France; National Reference Center for Auto-Inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), France; ERN RITA (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Disease Network), Utrecht, the Netherlands.

V. Hentgen, MD, National Reference Center for Auto-Inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), France; Pediatric Department, Versailles Hospital, Le Chesnay, France; CEREMAIA Working Group, Paris, France.

G. Boursier, PhD, National Reference Center for Auto-Inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), France; CEREMAIA Working Group, Paris, France; Department of Molecular Genetics and Cytogenomics, Rare and Auto Inflammatory Diseases Unit, CHU Montpellier, CEREMAIA, IRMB, INSERM, University of Montpellier, Montpellier, France.

I. Kone-Paut, PhD, National Reference Center for Auto-Inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), France; ERN RITA (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Disease Network), Utrecht, the Netherlands; CEREMAIA Working Group, Paris, France; Pediatric Rheumatology Department, Kremlin Bicêtre Hospital, AP-HP, Le Kremlin Bicêtre, France.

S. Georgin-Lavialle, PhD, Sorbonne University, Internal Medicine Department, DMU3ID, FHU INFLAMME, Tenon Hospital, AP-HP, Paris, France; National Reference Center for Auto-Inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), France; ERN RITA (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Disease Network), Utrecht, the Netherlands.